Dombret H - Search Results

1

Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia.

Guénot C, Lacombe F, Allou K, Dumezy F, Feuillard J, Geneviève F, Guérin E, Guy J, Maynadié M, Ballon OW, Preudhomme C, Baruchel A, Dombret H, Ifrah N, Béné MC; Groupe d’Etude Immunologique des Leucémies (GEIL). Guénot C, et al. Among authors: dombret h. Leukemia. 2019 Jul;33(7):1814-1816. doi: 10.1038/s41375-019-0393-0. Epub 2019 Feb 5. Leukemia. 2019. PMID: 30723257 No abstract available.

2

Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.

Brice P, Marolleau JP, Dombret H, Lepage E, Baruchel A, Adam M, Miclea JM, Sitthy X, Gisselbrecht C. Brice P, et al. Among authors: dombret h. Bone Marrow Transplant. 1992 May;9(5):337-42. Bone Marrow Transplant. 1992. PMID: 1352162

3

Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.

Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L. Dombret H, et al. Leukemia. 1992 Dec;6(12):1237-42. Leukemia. 1992. PMID: 1453767

4

In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.

Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L. Dombret H, et al. Leukemia. 1995 Jan;9(1):19-24. Leukemia. 1995. PMID: 7531260

5

Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?

Dombret H, Geiger S, Daniel MT, Glaisner S, Micléa JM, Castaigne S, Merle-Beral H, Lacombe C, Chomienne C, Degos L. Dombret H, et al. Leukemia. 1995 Sep;9(9):1473-7. Leukemia. 1995. PMID: 7658714

6

Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.

Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L. Dombret H, et al. Leukemia. 1993 Jan;7(1):2-9. Leukemia. 1993. PMID: 8418375

7

All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.

Seale J, Delva L, Renesto P, Balitrand N, Dombret H, Scrobohaci ML, Degos L, Paul P, Chomienne C. Seale J, et al. Among authors: dombret h. Leukemia. 1996 Jan;10(1):95-101. Leukemia. 1996. PMID: 8558945

8

Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie.

Gardin C, Chaibi P, de Revel T, Rousselot P, Turlure P, Micléa JM, Nédellec G, Dombret H. Gardin C, et al. Among authors: dombret h. Leukemia. 1997 Jan;11(1):16-21. doi: 10.1038/sj.leu.2400536. Leukemia. 1997. PMID: 9001413 Clinical Trial.

9

G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacy.

Da Silva N, Meyer-Monard S, Menot ML, Degos L, Baruchel A, Dombret H, Chomienne C. Da Silva N, et al. Among authors: dombret h. Cytokines Cell Mol Ther. 1997 Jun;3(2):75-80. Cytokines Cell Mol Ther. 1997. PMID: 9287246

10

Granulocyte colony-stimulating factor in combination with intensive chemotherapy in the treatment of acute myeloid leukemia.

Dombret H. Dombret H. Leuk Res. 1998 Dec;22(12):1137-42. doi: 10.1016/s0145-2126(98)00111-8. Leuk Res. 1998. PMID: 9922077 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters